Annual accounts receivable:
$552.50M+$40.50M(+7.91%)Summary
- As of today (May 31, 2025), WST annual accounts receivable is $552.50 million, with the most recent change of +$40.50 million (+7.91%) on December 31, 2024.
- During the last 3 years, WST annual accounts receivable has risen by +$63.50 million (+12.99%).
- WST annual accounts receivable is now at all-time high.
Performance
WST Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$543.60M-$8.90M(-1.61%)Summary
- As of today (May 31, 2025), WST quarterly accounts receivable is $543.60 million, with the most recent change of -$8.90 million (-1.61%) on March 31, 2025.
- Over the past year, WST quarterly accounts receivable has increased by +$19.60 million (+3.74%).
- WST quarterly accounts receivable is now -1.61% below its all-time high of $552.50 million, reached on December 31, 2024.
Performance
WST Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
WST Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.9% | +3.7% |
| 3 y3 years | +13.0% | +9.0% |
| 5 y5 years | +73.0% | +63.2% |
WST Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +13.0% | -1.6% | +13.4% |
| 5 y | 5-year | at high | +73.0% | -1.6% | +63.2% |
| alltime | all time | at high | +928.9% | -1.6% | +912.3% |
WST Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $543.60M(-1.6%) |
| Dec 2024 | $552.50M(+7.9%) | $552.50M(+5.4%) |
| Sep 2024 | - | $524.30M(+9.4%) |
| Jun 2024 | - | $479.40M(-8.5%) |
| Mar 2024 | - | $524.00M(+2.3%) |
| Dec 2023 | $512.00M(+0.9%) | $512.00M(-1.4%) |
| Sep 2023 | - | $519.10M(-2.9%) |
| Jun 2023 | - | $534.40M(+4.1%) |
| Mar 2023 | - | $513.40M(+1.2%) |
| Dec 2022 | $507.40M(+3.8%) | $507.40M(+4.6%) |
| Sep 2022 | - | $485.30M(-8.2%) |
| Jun 2022 | - | $528.40M(+6.0%) |
| Mar 2022 | - | $498.70M(+2.0%) |
| Dec 2021 | $489.00M(+26.9%) | $489.00M(+2.6%) |
| Sep 2021 | - | $476.40M(-0.9%) |
| Jun 2021 | - | $480.50M(+3.2%) |
| Mar 2021 | - | $465.70M(+20.9%) |
| Dec 2020 | $385.30M(+20.7%) | $385.30M(+3.3%) |
| Sep 2020 | - | $373.00M(+9.5%) |
| Jun 2020 | - | $340.60M(+2.3%) |
| Mar 2020 | - | $333.00M(+4.3%) |
| Dec 2019 | $319.30M(+10.8%) | $319.30M(+1.0%) |
| Sep 2019 | - | $316.10M(-4.4%) |
| Jun 2019 | - | $330.80M(+4.0%) |
| Mar 2019 | - | $318.20M(+10.4%) |
| Dec 2018 | $288.20M(+13.8%) | $288.20M(-4.9%) |
| Sep 2018 | - | $302.90M(+2.1%) |
| Jun 2018 | - | $296.70M(+2.2%) |
| Mar 2018 | - | $290.40M(+14.7%) |
| Dec 2017 | $253.20M(+26.3%) | $253.20M(+0.6%) |
| Sep 2017 | - | $251.80M(+3.9%) |
| Jun 2017 | - | $242.40M(+7.8%) |
| Mar 2017 | - | $224.80M(+12.1%) |
| Dec 2016 | $200.50M(+10.5%) | $200.50M(-4.3%) |
| Sep 2016 | - | $209.50M(-4.3%) |
| Jun 2016 | - | $219.00M(+4.5%) |
| Mar 2016 | - | $209.60M(+15.5%) |
| Dec 2015 | $181.40M(+1.3%) | $181.40M(-6.8%) |
| Sep 2015 | - | $194.60M(-2.1%) |
| Jun 2015 | - | $198.80M(+4.9%) |
| Mar 2015 | - | $189.50M(+5.9%) |
| Dec 2014 | $179.00M(-3.6%) | $179.00M(-8.6%) |
| Sep 2014 | - | $195.90M(-6.5%) |
| Jun 2014 | - | $209.60M(+0.4%) |
| Mar 2014 | - | $208.70M(+12.4%) |
| Dec 2013 | $185.70M | $185.70M(-6.3%) |
| Sep 2013 | - | $198.20M(+1.5%) |
| Jun 2013 | - | $195.30M(+3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $189.00M(+8.0%) |
| Dec 2012 | $175.00M(+18.9%) | $175.00M(-4.3%) |
| Sep 2012 | - | $182.90M(-1.1%) |
| Jun 2012 | - | $185.00M(+5.1%) |
| Mar 2012 | - | $176.00M(+19.6%) |
| Dec 2011 | $147.20M(+16.5%) | $147.20M(-3.9%) |
| Sep 2011 | - | $153.10M(-7.6%) |
| Jun 2011 | - | $165.70M(+2.8%) |
| Mar 2011 | - | $161.20M(+27.5%) |
| Dec 2010 | $126.40M(-8.9%) | $126.40M(-11.5%) |
| Sep 2010 | - | $142.80M(-2.0%) |
| Jun 2010 | - | $145.70M(-0.6%) |
| Mar 2010 | - | $146.60M(+5.7%) |
| Dec 2009 | $138.70M(+7.9%) | $138.70M(-2.7%) |
| Sep 2009 | - | $142.50M(-0.6%) |
| Jun 2009 | - | $143.40M(+4.5%) |
| Mar 2009 | - | $137.20M(+6.7%) |
| Dec 2008 | $128.60M(-5.5%) | $128.60M(-8.5%) |
| Sep 2008 | - | $140.60M(-11.7%) |
| Jun 2008 | - | $159.20M(+4.8%) |
| Mar 2008 | - | $151.90M(+11.6%) |
| Dec 2007 | $136.10M(+24.3%) | $136.10M(-0.5%) |
| Sep 2007 | - | $136.80M(+0.1%) |
| Jun 2007 | - | $136.70M(-4.6%) |
| Mar 2007 | - | $143.30M(+30.9%) |
| Dec 2006 | $109.50M(+2.0%) | $109.50M(-8.9%) |
| Sep 2006 | - | $120.20M(-3.3%) |
| Jun 2006 | - | $124.30M(+0.1%) |
| Mar 2006 | - | $124.20M(+15.6%) |
| Dec 2005 | $107.40M(+47.3%) | $107.40M(+2.5%) |
| Sep 2005 | - | $104.80M(+1.5%) |
| Jun 2005 | - | $103.30M(+22.5%) |
| Mar 2005 | - | $84.30M(+15.6%) |
| Dec 2004 | $72.90M(+0.8%) | $72.90M(-7.5%) |
| Sep 2004 | - | $78.80M(-2.7%) |
| Jun 2004 | - | $81.00M(+12.0%) |
| Dec 2003 | $72.30M(+8.6%) | $72.30M(-5.2%) |
| Sep 2003 | - | $76.30M(-5.7%) |
| Jun 2003 | - | $80.90M(+11.4%) |
| Mar 2003 | - | $72.60M(+9.0%) |
| Dec 2002 | $66.60M(+7.8%) | $66.60M(+5.4%) |
| Sep 2002 | - | $63.20M(-10.6%) |
| Jun 2002 | - | $70.70M(-0.3%) |
| Mar 2002 | - | $70.90M(+14.7%) |
| Dec 2001 | $61.80M(+15.1%) | $61.80M(-17.6%) |
| Sep 2001 | - | $75.00M(+7.6%) |
| Jun 2001 | - | $69.70M(+29.8%) |
| Dec 2000 | $53.70M | $53.70M |
FAQ
- What is West Pharmaceutical Services annual accounts receivable?
- What is the all time high annual accounts receivable for West Pharmaceutical Services?
- What is West Pharmaceutical Services annual accounts receivable year-on-year change?
- What is West Pharmaceutical Services quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for West Pharmaceutical Services?
- What is West Pharmaceutical Services quarterly accounts receivable year-on-year change?
What is West Pharmaceutical Services annual accounts receivable?
The current annual accounts receivable of WST is $552.50M
What is the all time high annual accounts receivable for West Pharmaceutical Services?
West Pharmaceutical Services all-time high annual accounts receivable is $552.50M
What is West Pharmaceutical Services annual accounts receivable year-on-year change?
Over the past year, WST annual accounts receivable has changed by +$40.50M (+7.91%)
What is West Pharmaceutical Services quarterly accounts receivable?
The current quarterly accounts receivable of WST is $543.60M
What is the all time high quarterly accounts receivable for West Pharmaceutical Services?
West Pharmaceutical Services all-time high quarterly accounts receivable is $552.50M
What is West Pharmaceutical Services quarterly accounts receivable year-on-year change?
Over the past year, WST quarterly accounts receivable has changed by +$19.60M (+3.74%)